Encouraging Start for New HCV Treatment Concept
Share
Follow Us
New Hepatitis C Treatment Shows Promise
Drug prevented virus from replicating in the livers of primates
By Jennifer Thomas
HealthDay Reporter
THURSDAY, Dec. 3 (HealthDay News) — A new drug to treat hepatitis C has shown promise in a primate study.
The drug, called SPC3649, uses a new strategy to prevent the hepatitis C virus from replicating. Unlike other antivirals that target the virus itself, the new DNA-based drug targets a small RNA molecule in the liver that hepatitis C needs to replicate, the researchers explained.
By inhibiting the molecule, SPC3649 reduced hepatitis C virus levels in the liver and in the bloodstream in chimpanzees that received the highest dose by 350-fold.
Continue reading the entire article:
http://health.usnews.com/articles/health/healthday/2009/12/03/new-hepatitis-c-treatment-shows-promise.html
